Combivir
300/150mg
Formulated to target HIV replication and indicated to support management of viral load in patients.
HIV Management Medications
HIV management medicines suppress viral replication and protect immune function through carefully combined antiretroviral therapy. This category helps compare drug classes, but real treatment choices depend on viral load, resistance history, interactions, and specialist monitoring.
Darunavir Tablets
600 · 800mg
developed to target human immunodeficiency virus infection to support immune system health.
Dolutegravir Tablets
50mg
indicated to support viral load reduction in patients with human immunodeficiency virus infection, to target viral replication.
Efavirenz Tablets
200 · 600mg
developed to manage hiv-1 infection indicated to target viral replication.
Epivir
150mg
Developed to manage hiv infection and chronic hepatitis b to support long-term viral suppression.
Epivir Hbv
100mg
indicated for chronic hepatitis b to support viral suppression and hepatocyte health.
Natdac
Tenofovir Disoproxil, Daclatasvir, Sofosbuvir
60mg
indicated to manage hepatitis c to mitigate viral infection.
Tenofovir
300mg
indicated to mitigate viral replication to support immune system health in chronic infection.
Tenofovir Emtricitabine
300/200mg
intended to relieve viral replication in human immunodeficiency virus infection to support immune stability.
Triumeq
Abacavir, Dolutegravir, Lamivudine
600/50/300mg
indicated for HIV infection to support viral suppression.
Viramune
200mg
Viramune is designed to target HIV to mitigate viral replication, utilized to support immune system function and to address long-term viral progression.
Viropil
Dolutegravir, Lamivudine, Tenofovir Disoproxil
50/300/300mg
Developed for human immunodeficiency virus infection indicated to support viral load suppression.
Zepdon
400mg
Indicated to target viral replication in HIV management formulated to mitigate disease progression.
What this category helps you sort out
Modern HIV treatment usually combines medicines that block different steps in the viral life cycle. The aim is sustained viral suppression, immune protection, and reduced transmission risk when treatment is effective and taken consistently.
Small differences matter: kidney function, hepatitis status, pregnancy, mental health history, resistance tests, and other medicines can all change which regimen is suitable.
How to compare options
- Identify the class: NRTI, NNRTI, integrase inhibitor, protease inhibitor, or booster-containing regimen.
- Check food requirements, missed-dose advice, kidney or liver monitoring, and interaction warnings.
- Review compatibility with contraception, antacids, supplements, tuberculosis medicines, seizure medicines, and recreational drugs.
- Avoid unsupervised switching, because resistance can limit future options.
Common medication groups
NRTIs and NNRTIs
NRTIs and NNRTIs interfere with reverse transcriptase, an enzyme HIV uses to copy its genetic material. They are often part of combination regimens rather than standalone treatment.
Integrase inhibitors
Integrase inhibitors block the virus from integrating into human DNA. They are common in current regimens, but mineral supplements and antacids can interfere with absorption for some products.
Protease inhibitors and boosters
Protease inhibitors disrupt viral maturation and may be boosted to raise drug levels. Boosters create many interaction checks, especially with heart, cholesterol, steroid, and sedative medicines.
Safety notes for this category
HIV treatment should stay linked to viral load, CD4 count, kidney and liver tests, sexual health screening, and resistance review where needed.
Missed doses, side effects, pregnancy, new medicines, or symptoms of acute infection should be discussed with an HIV clinician or pharmacist.
Important Safety Information
HIV medicines are regimen-based and interaction-sensitive. This page is educational and does not replace specialist HIV care, viral-load monitoring, resistance testing, or product-specific instructions.